Micro Emerging Active

BMY Camzyos successo studio Fase 3

New narrative with limited coverage — still forming.

Punteggio
0,4
Velocità
▲ 1,0
Articoli
2
Fonti
2

Sentiment Timeline

Event Timeline

Apr 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
Apr 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

Cronologia

Prima apparizioneApr 02, 2026
Ultimo aggiornamentoApr 02, 2026